๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
Trackers Drugs Comparisons API
Trackers Clinical trials Obesity
Clinical trial register · Ireland

Obesity Trials in Ireland

Every study on the ClinicalTrials.gov registry that lists a site in Ireland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Alert me on this filter Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 616 matching records held by the registry are in this view. Synced 17 Sep 2026, 08:22 UTC
616
Studies in scope
all four open statuses
324
Recruiting now
open to new participants
181
Lead sponsors
across recruiting studies
1
Irish site locations
across all listed studies
Phase mix of the 324 recruiting studies
Phase 3 99 Not applicable 79 Observational 76 Phase 2 30 Phase 1/2 20 Other 20
Narrow the register Reset
Matches title, registry number, sponsor, intervention and condition.
Recruitment status
Phase
Site location
Dublin 2
All 1 locations
Target enrolment
to
2 of 616 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Irish sites
Start
Recruiting
Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV
NCT04174755 Obesity, HIV-1-infection
University College Dublin
Not applicable
80
Dublin
2022-06-22
Recruiting
Medication Following Bariatric Surgery for Type 2 Diabetes Mellitus
NCT04432025 Obesity, Type 2 Diabetes
Imperial College London
Not applicable
150
Dublin
2021-04-01
Rows per page Showing 1–2 of 2
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Irish investigative site, filtered. Derived from ClinicalTrials.gov, U.S. National Library of Medicine. Retrieved 17 September 2026. https://priyalifescience.com/clinical-trials-ireland/condition/obesity

Query this register directly
GET /api/trials?country=ie&status=recruiting&phase=Phase+3&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see the EU Clinical Trials Tracker.